Molecular & Translational Research

This session explores the latest advances in understanding the molecular mechanisms underlying thyroid cancer. Experts will discuss key genetic drivers, including BRAF, RET, and RAS mutations, and their implications for disease progression. Attendees will learn about novel biomarkers that enable early detection and patient stratification. Translational research bridging laboratory discoveries with clinical application will be highlighted. The session emphasizes how molecular insights can guide targeted therapy and precision medicine approaches.

Targeted Therapies & Systemic Treatment

This session focuses on the evolving landscape of systemic therapies for thyroid cancer. Presentations will cover tyrosine kinase inhibitors, immunotherapies, and combination strategies for advanced or radioiodine-refractory disease. Experts will share outcomes from recent clinical trials and practical guidelines for treatment selection. The session will examine challenges in therapy resistance and approaches to overcome them. Delegates will gain insight into integrating novel treatments into standard care pathways.

: Nuclear Medicine, Imaging & Theranostics

Attendees will explore cutting-edge imaging technologies and theranostic approaches for thyroid cancer. Topics include molecular imaging, radioiodine dosimetry, and PET/CT innovations that enhance diagnosis and treatment planning. The session will discuss personalized radioiodine therapy guided by molecular profiling. Advances in theranostics highlight how imaging and treatment can be combined for optimal patient outcomes. Clinical applications and emerging research will be emphasized throughout the session

Surgical Innovations & Clinical Practice

This session examines modern surgical approaches in thyroid cancer management. Experts will present minimally invasive and robotic-assisted thyroidectomy techniques, emphasizing patient safety and postoperative outcomes. Intraoperative nerve monitoring and surgical risk reduction strategies will be discussed. Attendees will learn how molecular and imaging insights inform surgical decision-making. The session highlights best practices for integrating innovation into everyday clinical workflows.

Patient Care, Survivorship & Multidisciplinary Management

This session addresses patient-centered care and long-term outcomes in thyroid cancer. Presentations will cover quality-of-life considerations, psychosocial support, and survivorship strategies. Multidisciplinary collaboration among endocrinologists, surgeons, oncologists, and allied healthcare professionals will be emphasized. Attendees will learn practical approaches for integrating patient preferences into clinical decision-making. The session underscores the importance of coordinated care and holistic management.

Emerging Technologies & Future Directions

This session highlights the role of AI, machine learning, and digital health in thyroid cancer research and care. Experts will present applications in imaging, predictive modeling, and treatment planning. Innovative therapeutic platforms, including CAR-T and novel small molecules, will be discussed. Attendees will explore how data-driven tools can enhance precision medicine. The session encourages forward-thinking strategies to accelerate research translation into clinical practice.